Secondary prevention after myocardial infarction: It takes two (physician and patient) to tango Academic Article uri icon

abstract

  • Non-adherence to guidelines is an obstacle for cardiovascular secondary prevention after acute myocardial infarction (AMI). Current guidelines for the management of patients with AMI recommend the use of four class-I evidence-based medications (4EBM): anti-platelet agents, β-blockers (BB), angiotensin-converting enzyme inhibitors (ACE-I) or angiotensin receptor blockers (ARB), and statins;[1] such treatment reduces the risk of cardiovascular events and mortality [2, 3]. While progressive improvement of in-hospital adherence to guidelines was achieved [4], less attention has been directed to postdischarge guideline adherence, in particular, the relative contributions of physicians vs. patients to non- adherence were not described. We sought to define predictors of cardiologist at hospital discharge, general practitioner (GP), and patient non-adherence to guidelines during the …

publication date

  • January 1, 2014